Theratechnologies Stock Revenue

THTX Stock  USD 1.20  0.01  0.83%   
Theratechnologies fundamentals help investors to digest information that contributes to Theratechnologies' financial success or failures. It also enables traders to predict the movement of Theratechnologies Stock. The fundamental analysis module provides a way to measure Theratechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theratechnologies stock.
Last ReportedProjected for Next Year
Total Revenue94 M98.7 M
At this time, Theratechnologies' Total Revenue is fairly stable compared to the past year. Cost Of Revenue is likely to rise to about 23.7 M in 2024, whereas Current Deferred Revenue is likely to drop slightly above 32.5 K in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Theratechnologies Company Revenue Analysis

Theratechnologies' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current Theratechnologies Revenue

    
  81.76 M  
Most of Theratechnologies' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Theratechnologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Historical and Projected quarterly revenue of Theratechnologies

Projected quarterly revenue analysis of Theratechnologies provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Theratechnologies match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Theratechnologies' stock price.

Theratechnologies Revenue Driver Correlations

Understanding the fundamental principles of building solid financial models for Theratechnologies is extremely important. It helps to project a fair market value of Theratechnologies Stock properly, considering its historical fundamentals such as Revenue. Since Theratechnologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Theratechnologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Theratechnologies' interrelated accounts and indicators.

Theratechnologies Revenue Historical Pattern

Today, most investors in Theratechnologies Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Theratechnologies' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Theratechnologies revenue as a starting point in their analysis.
   Theratechnologies Revenue   
       Timeline  
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

Theratechnologies Current Deferred Revenue

Current Deferred Revenue

32,490

At this time, Theratechnologies' Current Deferred Revenue is fairly stable compared to the past year.
Based on the latest financial disclosure, Theratechnologies reported 81.76 M of revenue. This is 98.93% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is 99.13% higher than that of the company.

Theratechnologies Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Theratechnologies' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics of similar companies.
Theratechnologies is currently under evaluation in revenue category among its peers.

Theratechnologies Current Valuation Drivers

We derive many important indicators used in calculating different scores of Theratechnologies from analyzing Theratechnologies' financial statements. These drivers represent accounts that assess Theratechnologies' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Theratechnologies' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap709.8M1.2B831.6M41.7M37.6M35.7M
Enterprise Value752.5M1.3B874.4M66.6M59.9M56.9M

Theratechnologies Institutional Holders

Institutional Holdings refers to the ownership stake in Theratechnologies that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Theratechnologies' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Theratechnologies' value.
Shares
Citadel Advisors Llc2024-09-30
38.1 K
Summit Trail Advisors, Llc2024-09-30
33.1 K
Bare Financial Services Inc2024-09-30
26.8 K
Beacon Pointe Advisors, Llc2024-06-30
26.5 K
Geode Capital Management, Llc2024-09-30
25.7 K
Bank Of Montreal2024-06-30
18.3 K
Bmo Capital Markets Corp.2024-06-30
18.3 K
Ubs Group Ag2024-06-30
17.5 K
Kohmann Bosshard Financial Services, Llc2024-09-30
15.4 K
Soleus Capital Management, L.p.2024-06-30
4.8 M
Morgan Stanley - Brokerage Accounts2024-06-30
4.5 M

Theratechnologies Fundamentals

About Theratechnologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Theratechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.